Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Mind Medicine (MindMed) Inc. - Common Shares (NQ:MNMD)

13.72 +0.21 (+1.55%)
Streaming Delayed Price Updated: 9:54 AM EST, Jan 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Mind Medicine (MindMed) Inc. - Common Shares

< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
34 35 Next >
News headline image
Psychedelic Stock Gainers And Losers From June 14, 2022 ↗
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 9.90% at $9.44 
Via Benzinga
News headline image
ATAI Life Sciences, Compass Pathways Among Top Psychedelic Movers Of Today ↗
GAINERS: Mind Medicine (NASDAQ:MNMD) shares closed up 1.06% at $0.81 LOSERS: 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From June 10, 2022 ↗
GAINERS: Cybin (AMEX:CYBN) shares closed up 6.16% at $0.67 
Via Benzinga
News headline image
Small Pharma, Cybin Among Top Psychedelic Movers Of Today ↗
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 12.55% at $0.13 
Via Benzinga
News headline image
Mind Medicine, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 7.70% at $0.78 
Via Benzinga
News headline image
Seelos Therapeutics, ATAI Life Sciences Among Top Psychedelic Movers Of Today ↗
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 9.47% at $0.72 
Via Benzinga
News headline image
ATAI Life Sciences, Mind Medicine Among Top Psychedelic Movers Of Today ↗
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 3.55% at $0.36 
Via Benzinga
News headline image
Jefferies Global Healthcare Conference: Three Psychedelic Biotech Companies To Participate This Week ↗
The 2022 Jefferies Global Healthcare Conference is an annual gathering where over 500 public & private healthcare companies and 3,000 leading executives, institutional investors, private equity... 
Via Benzinga
News headline image
Awakn Life Sciences Files Patent For Exclusive Rights To Use Ketamine For Treating Behavioral Addictions ↗
Photo by Adrien Converse on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From June 3, 2022 ↗
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 5.88% at $0.35 
Via Benzinga
News headline image
Cybin, GH Research Among Top Psychedelic Movers Of Today ↗
GAINERS: Cybin (AMEX:CYBN) shares closed up 9.50% at $0.75 
Via Benzinga
News headline image
These 18 Clinical Trials Could Shape The Future Of The Psychedelics Industry ↗
In the nascent industry of medical psychedelics, drug development is the name of the game. This subset of biotech, poised to become a $100 billion industry according to Canaccord Genuity, bases its... 
Via Benzinga
News headline image
ATAI Life Sciences, Intelgenx Technologies Among Top Psychedelic Movers Of Today ↗
GAINERS: Field Trip Health (NASDAQ:FTRP) shares closed up 7.05% at $0.91 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From May 31, 2022 ↗
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 8.54% at $0.36 
Via Benzinga
News headline image
Psychedelic Compounds-Based Stocks Continue To Decline ↗
Our index tracks 6 of the largest clinical-stage startups, which have an average market capitalization of $65.5M and an average stock price of $0.69/share. 
Via Talk Markets
News headline image
Psychedelic Stock Gainers And Losers From May 26, 2022 ↗
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 21.06% at $0.34 
Via Benzinga
News headline image
TripAdvisor, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗
GAINERS: TripAdvisor (NASDAQ:TRIP) shares closed up 6.06% at $23.45 
Via Benzinga
News headline image
Psyched: Medical Psychedelics In Davos, Canadian Sen Does Psychedelics, Ei.Ventures & Mycotopia To Merge Into $383M Company ↗
Medical Psychedelics have made it into Davos, just in time for the World Economic Forum. 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From May 24, 2022 ↗
GAINERS: LOSERS: Cybin (AMEX:CYBN) shares closed down 9.99% at $0.61 
Via Benzinga
News headline image
Cannabis Movers & Shakers: Mind Medicine, 22nd Century Group, Grown Rogue International ↗
Mind Medicine Names New CEO Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) has hired Schond L. Greenway to oversee its finance department. 
Via Benzinga
News headline image
Cybin, Small Pharma Among Top Psychedelic Movers Of Today ↗
GAINERS: Cybin (AMEX:CYBN) shares closed up 15.60% at $0.68 
Via Benzinga
News headline image
MindMed Appoints Schond L. Greenway As CFO ↗
Mind Medicine Inc. (NASDAQ: MNMD), (NEO:MMED), a clinical stage bio-pharmaceutical company developing novel products to treat brain health disorders, appointed Schond L. Greenway as CFO. 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From May 20, 2022 ↗
GAINERS: Mind Medicine (NASDAQ:MNMD) shares closed up 8.33% at $0.77 
Via Benzinga
News headline image
Revive Therapeutics, Allied Among Top Psychedelic Movers Of Today ↗
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 21.90% at $0.29 
Via Benzinga
News headline image
MindMed Reports Promising Results For Non-Hallucinogenic Ibogaine Congener Substance ↗
MindMed Inc. (NASDAQ: MNMD) reported favorable results for one of its proprietary compounds. 
Via Benzinga
News headline image
Cybin, Allied Among Top Psychedelic Movers Of Today ↗
GAINERS: Cybin (AMEX:CYBN) shares closed up 13.43% at $0.55 
Via Benzinga
News headline image
Intelgenx Technologies, Cybin Among Top Psychedelic Movers Of Today ↗
GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 16.85% at $0.32 
Via Benzinga
News headline image
Psyched: Compass, Atai And MindMed Release Q1 Earnings, Phase 3 MDMA Trial Closer To Completion, Enveric Splits Into Two Companies ↗
The psychedelics space got a new glimpse at the financials of some of its heavy hitters with the release of earnings reports for the first quarter of 2022. 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From May 16, 2022 ↗
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 25.00% at $0.22 
Via Benzinga
News headline image
MindMed Reports Financial Results For Q1, With Lower Cash Balance Compared To December Last Year ↗
MindMed (NASDAQ: MNMD) announced its financial results for the first quarter of 2022, which ended March 31. 
Via Benzinga
< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
34 35 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.